Details
Stereochemistry | ACHIRAL |
Molecular Formula | C25H32O2S |
Molecular Weight | 396.585 |
Optical Activity | NONE |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 1 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
CCS(=O)(=O)C1=CC=C(C=C1)\C=C(/C)C2=CC=C3C(=C2)C(C)(C)CCC3(C)C
InChI
InChIKey=UDAZCXVIYSIEFX-FBMGVBCBSA-N
InChI=1S/C25H32O2S/c1-7-28(26,27)21-11-8-19(9-12-21)16-18(2)20-10-13-22-23(17-20)25(5,6)15-14-24(22,3)4/h8-13,16-17H,7,14-15H2,1-6H3/b18-16+
Etarotene (Ro 15-1570) is an arotinoid sulfone. Etarotene inhibits RNase P, a ribonucleoprotein that endonucleolytically cleaves all tRNA precursors to produce the mature 5' end, thereby affecting tRNA biogenesis. Etarotene has antikeratinizing potential. It was undergoing phase III clinical trials with Roche in the US for the treatment of psoriasis and other skin.
Originator
Approval Year
PubMed
Title | Date | PubMed |
---|---|---|
Quantitative analysis of retinoids in biological fluids by high-performance liquid chromatography using column switching. III. Determination of the arotinoid sumarotene and its Z-isomer in human and animal plasma. | 1992 Apr 15 |
|
Regulation of the induction of ornithine decarboxylase in keratinocytes by retinoids. | 1995 Jul 1 |
|
Phorbol 12-myristate 13-acetate inhibits epidermal growth factor signalling in human keratinocytes, leading to decreased ornithine decarboxylase activity. | 1996 Oct 15 |
|
Inhibitory effects of arotinoids on tRNA biogenesis. | 2000 Nov-Dec |
Name | Type | Language | ||
---|---|---|---|---|
|
Official Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Code | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
NCI_THESAURUS |
C804
Created by
admin on Fri Dec 15 16:49:18 GMT 2023 , Edited by admin on Fri Dec 15 16:49:18 GMT 2023
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
C96705
Created by
admin on Fri Dec 15 16:49:18 GMT 2023 , Edited by admin on Fri Dec 15 16:49:18 GMT 2023
|
PRIMARY | |||
|
SUB07264MIG
Created by
admin on Fri Dec 15 16:49:18 GMT 2023 , Edited by admin on Fri Dec 15 16:49:18 GMT 2023
|
PRIMARY | |||
|
CHEMBL2106243
Created by
admin on Fri Dec 15 16:49:18 GMT 2023 , Edited by admin on Fri Dec 15 16:49:18 GMT 2023
|
PRIMARY | |||
|
100000082390
Created by
admin on Fri Dec 15 16:49:18 GMT 2023 , Edited by admin on Fri Dec 15 16:49:18 GMT 2023
|
PRIMARY | |||
|
87719-32-2
Created by
admin on Fri Dec 15 16:49:18 GMT 2023 , Edited by admin on Fri Dec 15 16:49:18 GMT 2023
|
PRIMARY | |||
|
6435463
Created by
admin on Fri Dec 15 16:49:18 GMT 2023 , Edited by admin on Fri Dec 15 16:49:18 GMT 2023
|
PRIMARY | |||
|
6737
Created by
admin on Fri Dec 15 16:49:18 GMT 2023 , Edited by admin on Fri Dec 15 16:49:18 GMT 2023
|
PRIMARY | |||
|
PD3817FE9N
Created by
admin on Fri Dec 15 16:49:18 GMT 2023 , Edited by admin on Fri Dec 15 16:49:18 GMT 2023
|
PRIMARY | |||
|
DTXSID101318671
Created by
admin on Fri Dec 15 16:49:18 GMT 2023 , Edited by admin on Fri Dec 15 16:49:18 GMT 2023
|
PRIMARY | |||
|
CC-39
Created by
admin on Fri Dec 15 16:49:18 GMT 2023 , Edited by admin on Fri Dec 15 16:49:18 GMT 2023
|
PRIMARY |
ACTIVE MOIETY